Details

Hypopituitarism and cardiovascular risk
ID Kraljević, Ivana (Author), ID Solak, Mirsala (Author), ID Mandić, Ante (Author), ID Mlekuš, Katarina (Author), ID Raičević, Maja (Author), ID Divanović Slato, Anida (Author), ID Kovačević, Zlata (Author), ID Muzurović, Emir (Author)

.pdfPDF - Presentation file, Download (626,41 KB)
MD5: CCDA4D689CC20F565393AE945F1426C8
URLURL - Source URL, Visit https://journals.sagepub.com/doi/10.1177/10742484251332398 This link opens in a new window

Abstract
Hypopituitarism, resulting from a partial or complete deficiency of anterior or posterior pituitary hormones, is associated with increased cardiovascular (CV) morbidity and mortality. This heterogeneous endocrinological disorder may arise from various etiologies, including genetic mutations, pituitary tumors, traumatic brain injury, and autoimmune diseases. Hypopituitarism often results in multiple endocrine deficits that contribute to metabolic dysregulation characterized by insulin resistance, dyslipidemia, and increased visceral adiposity, all known risk factors for CV disease (CVD). Additionally, the presence of chronic inflammation and endothelial dysfunction further increases the risk of CVD in these patients. While standard hormone replacement therapy (HRT) is crucial for restoring hormonal balance, it can sometimes have adverse metabolic effects that can exacerbate atherosclerosis and CVD. Emerging evidence suggests that optimizing HRT regimens and addressing specific hormone deficiencies, such as growth hormone and cortisol, may reduce these risks and improve CV outcomes. This review comprehensively analyzes the etiology, pathophysiological mechanisms underlying CV risk in anterior pituitary dysfunction, and treatment strategies to mitigate CV morbidity and mortality in patients with hypopituitarism.

Language:English
Keywords:hypopituitarism, cardiovascular risk, cardiovascular disease, GH deficiency, hormone replacement therapy
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:22 str.
Numbering:Vol. 30
PID:20.500.12556/RUL-182308 This link opens in a new window
UDC:616.1
ISSN on article:1940-4034
DOI:10.1177/1074248425133239 This link opens in a new window
COBISS.SI-ID:275553027 This link opens in a new window
Publication date in RUL:07.05.2026
Views:247
Downloads:164
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of cardiovascular pharmacology and therapeutics
Publisher:Sage
ISSN:1940-4034
COBISS.SI-ID:3177236 This link opens in a new window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:Slovenian
Keywords:hipopituitarizem, kardiovaskularno tveganje, kardiovaskularna bolezen, pomanjkanje rastnega hormona, nadomestno hormonsko zdravljenje

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back